Evaluation of KRAS mutation subtype on survival in patients with metastatic non-small cell lung cancer receiving immunotherapy

被引：0

作者：

Barron, C. C. ^{[1
]}

Kuang, S. ^{[1
]}

Makarem, M. ^{[1
]}

Elliott, M. J. ^{[1
]}

Sharma, K. ^{[1
]}

Lee, J. ^{[1
]}

Schmid, S. ^{[1
]}

Rabinovitch, A. ^{[1
]}

Bradbury, P. ^{[1
]}

Liu, G. ^{[1
]}

Shepherd, F. A. ^{[1
]}

Tsao, M. S. ^{[1
]}

Leighl, N. ^{[1
]}

Rose, A. ^{[2
]}

Pezo, R. ^{[3
]}

Doherty, M. ^{[4
]}

Cheng, S. ^{[3
]}

Lau, S. C. ^{[1
]}

Sacher, A. ^{[1
]}

机构：

[1] Univ Hlth Network, Med Oncol, UHN, Princess Margaret Canc Ctr, Toronto, ON, Canada

[2] Jewish Gen Hosp, Segal Canc Ctr, Med Oncol, Montreal, PQ, Canada

[3] Odette Canc Ctr, Med Oncol, Toronto, ON, Canada

[4] Beaumont Hosp, Med Oncol, Dublin, Ireland

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

关键词：

D O I：

10.1016/j.annonc.2021.08.263

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1809P

引用

页码：S1229 / S1230

页数：2

共 50 条

[21] KRAS in non-small cell lung cancer
Amanam, I.
Gupta, R.
Mambetsariev, I.
Koczywas, M.
Cristea, M.
Massarelli, E.
Reckamp, K. L.
Salgia, R.
ANNALS OF ONCOLOGY, 2017, 28
[22] KRAS mutation is highly correlated with EGFR alterations in patients with non-small cell lung cancer
Wang, J. -Y.
Lin, S. -R.
EJC SUPPLEMENTS, 2009, 7 (04): : 37 - 37
[23] Molecular Characteristics and the Effect of KRAS Mutation on the Prognosis of Immunotherapy in Non-Small Cell Lung Cancer in Xinjiang, China
Gu, Guomin
Yu, Bo
Wan, Hua
Lu, Suqiong
Zhu, Xiaodan
Zhao, Yan
Fuxi, Yujing
Liu, Chunling
ONCOTARGETS AND THERAPY, 2022, 15 : 1021 - 1032
[24] The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis
Zhao, Rui
Shu, Yang
Xu, Wei
Jiang, Fengxian
Ran, Pancen
Pan, Liying
Wang, Jingliang
Wang, Weihao
Zhao, Jing
Wang, Yahui
Fu, Guobin
CANCER CELL INTERNATIONAL, 2024, 24 (01)
[25] KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer
Nelson, H. H.
Christensen, B. C.
Plaza, S. L.
Wiencke, J. K.
Marsit, C. J.
Kelsey, K. T.
LUNG CANCER, 2010, 69 (01) : 51 - 53
[26] Automated and rapid KRAS mutation testing in non-small cell lung cancer
Recondo, G.
Akselrad, S.
Jauk, F.
Teves, P.
Pandolfi, J.
Basbus, L.
Cortes, C. A. Franco
Rivello, H. Garcia
Marull, R. Sanchez
Powazniak, Y.
Calderazzo, J.
Bluthgen, M. V.
Sena, S. N.
Perfetti, A.
Levit, P. P.
Castagneris, N.
Rizzo, M. M.
Lupinacci, L.
Minatta, J. N.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S968 - S968
[27] The Effect of Radiotherapy on Clinical Outcomes for Patients Receiving Immunotherapy for Metastatic Non-Small Cell Lung Carcinoma
D'Rummo, K. A.
Al-Jumayli, M.
Huang, C. H.
Wang, F.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E501 - E502
[28] Prevalence of KRAS p.G12C mutation in patients with metastatic non-small cell lung cancer in Argentina
Mendoza Bertelli, Andrea
Otero Pizarro, Maria Mercedes
Fernandez, Maria Paz
Dibarbora, Delfina
Florencia Cantarella, Maria
Damian Mahmoud, Yamil
Girotti, Romina
Guttlein, Leandro
Chico, Isagani
Brandalise, Patricia
Dutra, Carolina
Salanova, Ruben
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[29] Immunotherapy Drug Improves Survival of Patients With Squamous Non-Small Cell Lung Cancer
不详
CANCER, 2015, 121 (20) : 3562 - 3563
[30] Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting
Yaniss Belaroussi
Fanny Bouteiller
Carine Bellera
David Pasquier
Maurice Perol
Didier Debieuvre
Thomas Filleron
Nicolas Girard
Roland Schott
Simone Mathoulin-Pélissier
Anne-Laure Martin
Sophie Cousin
Scientific Reports, 13

← 1 2 3 4 5 →